Brought to you by 
Abbott gets US, Canadian rights to Micro Therapeutics' line
15 Nov 1999
Executive Summary
Abbott Laboratories has signed a 10-year agreement to market Micro Therapeutics Inc.'s current and future diagnostic, prophylactic, and therapeutic technologies and products for blood clot disorders in the peripheral vasculature, in the US and Canada.
Deal Industry
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Abbott gets US, Canadian rights to Micro Therapeutics' line
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice